Chemotherapy of Malignant Tumors

Article1 May 1959CHEMOTHERAPY OF MALIGNANT TUMORSL. F. LARIONOVL. F. LARIONOVSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-50-5-1122 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Excerpt(Corresponding member of the Academy of Medical Sciences of the U.S.S.R.)A development of the problem of the drug therapy of cancer is possible along two main roads. The first is the development of methods for the medicinal stimulation of the protective forces of the organism in relation to the developing tumor, for the purpose of obtaining a regression of the process or, at least, the cessation of its further spread. The second is the search for medicinal preparations which can bring about the death of the tumor by means of direct interference with the metabolism of the malignant tissue...Bibliography1. Blokhin NN: Theses and reports of the Tenth Session of the General Meeting of the Academy of Medical Sciences of the U.S.S.R., 1956, Moscow, p. 61. Google Scholar2. Vermel EM: Contemporary problems of oncology, Moscow, 3: 78, 1956. Google Scholar3. VermelKramorenko EMIT (a) : Preliminary results of omaine therapy of cutaneous cancer, Voprosy Onkologii 1(4): 69, 1955. (b) Vol'fson, N. I.: Problems of oncology, 1952, Moscow 4: p. 235. MedlineGoogle Scholar4. Grushina AA: Effect of phosphoric acid triethylenediamine on nucleic acid metabolism (ribonucleic and desoxyribonucleic acids) in transplanted rat carcinoma 45, Voprosy Onkologii 1(4): 51, 1955. MedlineGoogle Scholar5. Zhdanov GL: Rational approach to therapy of cancer with haloalkylamines and with ethylenemelanines, Biull. Eksp. Biol. Med. 40(9): 65, 1955. MedlineGoogle Scholar6. KiselevMen'shikovBeer VVGPAA: Composition of colchicerine and a new alkaloid, colchamine, Doklady Acad. Nauk S.S.S.R. 87: 227, 1952. Google Scholar7. KnunyantsKil'dishevaGolubeva ILOVNE: Synthesis of cancerolytic peptides, Izvest. Akad. Nauk S.S.S.R., Otdel. Khim. Nauk 11: 1418, 1956. Google Scholar8. Larionov LF: Novoembikhin, Sovet. Med. 20(8): 59, 1956. MedlineGoogle Scholar9. Larionov LF: The treatment of lymphogranulomatosis and leukemia by means of Embikhin, 1951, Academy of Medical Sciences, U.S.S.R., Moscow. Google Scholar10. Larionov LF: Immediate and remote results of chloroethylamine treatment of Hodgkin's disease, Brit. M. J. 1: 252, 1956. CrossrefMedlineGoogle Scholar11. LarionovPlatonova LFGN: Antineoplastic effect of 4-methyl-5-di-(chloro-ethyl)-amino-uracil (dopane), Voprosy Onkologii 1(5): 36, 1955. MedlineGoogle Scholar12. LarionovLitvinovaKholdin LFEVSA: Chemotherapy of mammary gland cancer metastases, Voprosy Onkologii 2(6): 717, 1956. MedlineGoogle Scholar13. LarionovKhokhlovSkhodinskaiaVasinaTrusheikinaNovikova LFASENOSVLMA: Anti-tumor action of p-bis (chloroethyl) aminophenylalanine (sarcolysin), Biull. Eksp. Biol. Med. 39(1): 48, 1955. MedlineGoogle Scholar14. Maevsky MM: Theses and reports of the Tenth Session of the General Meeting of the Academy of Medical Sciences of the U.S.S.R., 1956, Moscow, p. 63. Google Scholar15. Movsesyan AK: Problems of oncology, 8th Ed., 1955, Moscow, p. 191. Google Scholar16. Rapoport YL: Problems of oncology, 4th Ed., 1952, Moscow, pp. 152, 301. Google Scholar17. Rozhdestvensky VI: Cancer of the prostate and its hormonal therapy, Diss., 1954, Leningrad. Google Scholar18. TopchanPomerantsev ABAA: Cancer of the prostate and its treatment by means of sinestrol, 1949, Medgiz, Moscow. Google Scholar19. Trusheikina VI: Carcinostatic effects of Sarcolysin on various experimental tumors in animals, Voprosy Onkologii 2(2): 222, 1956. MedlineGoogle Scholar20. Chebotareva LI: Experience in treating seminoma of the testes and its metastases with Sarcolysin, Voprosy Onkologii 2(3): 333, 1956. Google Scholar21. ChernorutskyGaukhmanBerger MVSLRG: News of medicine, No. 18, 1950, p. 30. Google Scholar22. Sharlikova LF: Appearance of resistance of rat sarcoma 45 to chloroethylamines and ethylene imines, Voprosy Onkologii 1(6): 74, 1955. MedlineGoogle Scholar23. BartzElderFrohardtFusariHaskellJohannessenRyder QRCCRPSATHDWA: Isolation and characterization of azaserine, Nature, London 173: 72, 1954. CrossrefMedlineGoogle Scholar24. Bergel F: Attempts at chemotherapy of malignant diseases, J. Pharm. and Pharmacol. 7: 297, 1955. CrossrefMedlineGoogle Scholar25. BergelStock FJA: Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalanines, J. Chem. Soc. London, p. 2409, 1954. Google Scholar26. BurchenalJohnstonStockParkerCrossleyKirkSeeger JHSFCCRPMLEDR: Effects of the N-ethylene substituted phosphoramides on transplantable mouse leukemia, Cancer Research 12: 251, 1952. Google Scholar27. Carow R (a) : Experiences with ST 52-ASTA in the treatment of carcinoma of the prostate, Ztschr. f. Urol. 47: 81, 1954. (b) Clarke, D. A., Philips, F. S., Sternberg, S. S., and Stock, C. C.: Effects of 6-mercaptopurine and analogs on experimental tumors, Ann. New York Acad. Sc. 60: 235, 1954. Google Scholar28. Farber S: Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer, Blood 4: 160, 1949. CrossrefMedlineGoogle Scholar29. Galton DA: Myleran in chronic myeloid leukaemia; results of treatment, Lancet 1: 208, 1953. CrossrefGoogle Scholar30. GilmanPhilips AFS: Biological actions and therapeutic applications of β-chloroethyl amines and sulfides, Science 103: 409, 1946. CrossrefGoogle Scholar31. Guidetti H: Preliminary reports on several cases of cancer treated with a cyanogenetic glycoside, Acta Unio Internat. contra Cancrum 11: 156, 1955. MedlineGoogle Scholar32. MagillGolbeyKarnofskyBurchenalStockRhoads GBRBDAJHCCCP: Clinical experiences with sarkomycin in neoplastic diseases, Cancer Research 16: 960, 1956. MedlineGoogle Scholar33. HaddowTimmis AGM: Bifunctional sulphonic acid esters with radiomimetic activity, Abstracts, 5th International Cancer Congress, 1950, Herman & Cie, Paris, p. 90. Google Scholar34. HendryMomerRoseWalpole JARFSLAL: Cytotoxic agents. III. Derivatives of ethyleneimine, Brit. J. Pharmacol. 6: 357, 1951. Google Scholar35. HooperCheneyCronFardigJohnsonJohnsonPalermitiSchmitzWheatley IRLCMJOBDADLFMHWB: Studies on sarkomycin, Antibiotics and Chemotherapy 5: 585, 1955. Google Scholar36. Huant E: Antitumoral action of a hypotoxic derivative of colchicine: deacetylthiocolchicine; clinical aspects and first therapeutic results: 16 case reports, Thérapie 10: 448, 1955. MedlineGoogle Scholar37. HugginsStevensHodges CRECV: Studies of prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland, Arch. Surg. 43: 209, 1941. CrossrefGoogle Scholar38. Ishiyama S: Clinical observations of some malignant tumors treated with sarkomycin, a new anti-tumor antibiotic, J. Antibiotics, Ser. A., Tokyo 7: 82, 1954. MedlineGoogle Scholar39. JacobsonSpurrGuzman BarronSmithLushbaughDick LOCLESTCGF: Studies on the effect of methyl-bis (beta-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of the hemopoietic system, J. A. M. A. 132: 263, 1946. CrossrefMedlineGoogle Scholar40. KonoTerashimaAzbumaMurata OHSY: A study of growth of ascites hepatoma and Yoshida sarcoma in rats and changes caused by Nitromin treatment, Gann, Tokyo 45: 536, 1954. MedlineGoogle Scholar41. MoeschlinGarson SH: Studies of ethyl alcohol therapy in experimental methyl alcohol poisoning, Schweiz. med. Wchnschr. 85: 61, 1955. MedlineGoogle Scholar42. ShearPerrault MJA: Chemical treatment of tumors. IX. Reactions of mice with primary subcutaneous tumors to injection of a hemorrhage-producing bacterial polysaccharide, J. Nat. Cancer Inst. 4: 461, 1944. Google Scholar43. Schulte G: Experiences with new cytostatic therapy in blood dyscrasias and carcinomata; differentiation of their effects from the effects of X-rays, Ztschr. f. Krebsforsch. 58: 500, 1952. CrossrefGoogle Scholar44. UmezawaTakeuchiNittaOkamiYamamotoYamaoka HTKYTS: Studies on anti-tumor substances produced by microorganisms. III. On sarkomycin produced by a strain resembling Streptomyces erythrochromogenes , J. Antibiotics, Ser. A., Tokyo 6: 147, 1953. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: MOSCOW, U.S.S.R.*Received for publication August 4, 1958.Translated from the Russian by Medical Documentation Service, Philadelphia, Pennsylvania.†Patol. Fiziol. i Eksper. Terap. 1 (3): 14-21, 1957.Requests for reprints should be addressed to Mr. Scott Adams, Librarian, National Institutes of Health, Bethesda 14, Maryland. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byChemotherapy of Cancer 1 May 1959Volume 50, Issue 5Page: 1122-1134KeywordsBiologicsChemotherapyDrug therapyFolic acidHormonal therapyMalignant tumorsNucleic acidsProteinsSarcoma ePublished: 1 December 2008 Issue Published: 1 May 1959 PDF downloadLoading ...